Sep 15, 2021 / 01:10PM GMT
Mike Ryskin - BofA Merrill Lynch - Analyst
Great. Thank you for joining us. My name is Mike Ryskin; I'm the Bank of America animal health analyst based in New York on the life science tools and diagnostics team. For our next session, we have Phibro Animal Health; and joining us from the Company is Damian Finio, CFO. Damian, thank you for being here.
Damian Finio - Phibro Animal Health Corporation - CFO
Good morning, Michael.
Questions and Answers:
Mike Ryskin - BofA Merrill Lynch - AnalystI think for the format today, we're going to stick with a fireside chat throughout. But if investors have questions, feel free to relay them via email or Bloomberg chat, or you can send them via the Veracast portal.
So, just to get the ball rolling, Damian. Phibro just reported fiscal 4Q a few weeks ago. Can you give us a brief recap of the key points from the earnings trend? Maybe recap the year as a whole. Certainly quite eventful.
Damian Finio - Phibro Animal Health Corporation - CFO<
Trustpilot
